By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Response Biomedical today reported that its fiscal-year 2010 revenues dropped 23 percent year over year on lower sales of products to partners and decreased service revenues.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.
An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.
In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.
The new Riken president outlines some of his plans for the institute.